97 related articles for article (PubMed ID: 18248818)
1. PTEN expression is a strong predictor of survival in mesothelioma patients.
Opitz I; Soltermann A; Abaecherli M; Hinterberger M; Probst-Hensch N; Stahel R; Moch H; Weder W
Eur J Cardiothorac Surg; 2008 Mar; 33(3):502-6. PubMed ID: 18248818
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of epithelial-mesenchymal transition in malignant pleural mesothelioma.
Schramm A; Opitz I; Thies S; Seifert B; Moch H; Weder W; Soltermann A
Eur J Cardiothorac Surg; 2010 Mar; 37(3):566-72. PubMed ID: 19781955
[TBL] [Abstract][Full Text] [Related]
3. Exploratory analysis of activation of PTEN-PI3K pathway and downstream proteins in malignant pleural mesothelioma (MPM).
Cedrés S; Montero MA; Martinez P; Martinez A; Rodríguez-Freixinós V; Torrejon D; Gabaldon A; Salcedo M; Ramon Y Cajal S; Felip E
Lung Cancer; 2012 Jul; 77(1):192-8. PubMed ID: 22459204
[TBL] [Abstract][Full Text] [Related]
4. Analysis of expression of PTEN/PI3K pathway and programmed cell death ligand 1 (PD-L1) in malignant pleural mesothelioma (MPM).
Cedrés S; Ponce-Aix S; Pardo-Aranda N; Navarro-Mendivil A; Martinez-Marti A; Zugazagoitia J; Sansano I; Montoro MA; Enguita A; Felip E
Lung Cancer; 2016 Jun; 96():1-6. PubMed ID: 27133741
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylated Akt overexpression and loss of PTEN expression in non-small cell lung cancer confers poor prognosis.
Tang JM; He QY; Guo RX; Chang XJ
Lung Cancer; 2006 Feb; 51(2):181-91. PubMed ID: 16324768
[TBL] [Abstract][Full Text] [Related]
6. PTEN protein expression in malignant pleural mesothelioma.
Agarwal V; Campbell A; Beaumont KL; Cawkwell L; Lind MJ
Tumour Biol; 2013 Apr; 34(2):847-51. PubMed ID: 23242608
[TBL] [Abstract][Full Text] [Related]
7. CD74: a new prognostic factor for patients with malignant pleural mesothelioma.
Otterstrom C; Soltermann A; Opitz I; Felley-Bosco E; Weder W; Stahel RA; Triponez F; Robert JH; Serre-Beinier V
Br J Cancer; 2014 Apr; 110(8):2040-6. PubMed ID: 24594996
[TBL] [Abstract][Full Text] [Related]
8. Integrin-linked kinase, phosphorylated AKT and the prognosis of malignant pleural mesothelioma.
Watzka SB; Setinek U; Stubenberger EB; Tötsch M; Dekan G; Marcher M; Fleck T; Müller MR
Eur J Cardiothorac Surg; 2011 Feb; 39(2):180-4. PubMed ID: 20580243
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological significance of PTEN loss and the phosphoinositide 3-kinase/Akt pathway in sporadic colorectal neoplasms: is PTEN loss predictor of local recurrence?
Colakoglu T; Yildirim S; Kayaselcuk F; Nursal TZ; Ezer A; Noyan T; Karakayali H; Haberal M
Am J Surg; 2008 Jun; 195(6):719-25. PubMed ID: 18440486
[TBL] [Abstract][Full Text] [Related]
10. First case report of malignant peritoneal mesothelioma and oral verrucous carcinoma in a patient with a germline PTEN mutation: a combination of extremely rare diseases with probable further implications.
Löffler MW; Steinhilber J; Hilke FJ; Haen SP; Bösmüller H; Montes-Mojarro IA; Bonzheim I; Stäbler A; Faust U; Grasshoff U; Königsrainer I; Rammensee HG; Kanz L; Königsrainer A; Beckert S; Riess O; Schroeder C
BMC Med Genet; 2018 Aug; 19(1):144. PubMed ID: 30111295
[TBL] [Abstract][Full Text] [Related]
11. Loss of expression of the PTEN gene protein product is associated with poor outcome in breast cancer.
Depowski PL; Rosenthal SI; Ross JS
Mod Pathol; 2001 Jul; 14(7):672-6. PubMed ID: 11454999
[TBL] [Abstract][Full Text] [Related]
12. [Prognosis related clinical and molecular factors in malignant pleural mesothelioma].
Wang YY; Zhang H; Bai H; Wang SH; Wu MN; An TT; Zhao J; Zhuo ML; Duan JC; Wang ZJ; Wang J
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Mar; 36(3):162-8. PubMed ID: 23856136
[TBL] [Abstract][Full Text] [Related]
13. Expression of interleukin-4 receptor alpha in human pleural mesothelioma is associated with poor survival and promotion of tumor inflammation.
Burt BM; Bader A; Winter D; Rodig SJ; Bueno R; Sugarbaker DJ
Clin Cancer Res; 2012 Mar; 18(6):1568-77. PubMed ID: 22261806
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological significance of nuclear PTEN expression in colorectal adenocarcinoma.
Jang KS; Song YS; Jang SH; Min KW; Na W; Jang SM; Jun YJ; Lee KH; Choi D; Paik SS
Histopathology; 2010 Jan; 56(2):229-39. PubMed ID: 20102402
[TBL] [Abstract][Full Text] [Related]
15. The role of PTEN and its signalling pathways, including AKT, in breast cancer; an assessment of relationships with other prognostic factors and with outcome.
Panigrahi AR; Pinder SE; Chan SY; Paish EC; Robertson JF; Ellis IO
J Pathol; 2004 Sep; 204(1):93-100. PubMed ID: 15307142
[TBL] [Abstract][Full Text] [Related]
16. CD26 overexpression is associated with prolonged survival and enhanced chemosensitivity in malignant pleural mesothelioma.
Aoe K; Amatya VJ; Fujimoto N; Ohnuma K; Hosono O; Hiraki A; Fujii M; Yamada T; Dang NH; Takeshima Y; Inai K; Kishimoto T; Morimoto C
Clin Cancer Res; 2012 Mar; 18(5):1447-56. PubMed ID: 22261805
[TBL] [Abstract][Full Text] [Related]
17. Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas.
Kurose K; Zhou XP; Araki T; Cannistra SA; Maher ER; Eng C
Am J Pathol; 2001 Jun; 158(6):2097-106. PubMed ID: 11395387
[TBL] [Abstract][Full Text] [Related]
18. Expression patterns of inhibitor of apoptosis proteins in malignant pleural mesothelioma.
Gordon GJ; Mani M; Mukhopadhyay L; Dong L; Edenfield HR; Glickman JN; Yeap BY; Sugarbaker DJ; Bueno R
J Pathol; 2007 Mar; 211(4):447-54. PubMed ID: 17253596
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneous lack of expression of the tumour suppressor PTEN protein in human neoplastic tissues.
Torres J; Navarro S; Roglá I; Ripoll F; Lluch A; García-Conde J; Llombart-Bosch A; Cervera J; Pulido R
Eur J Cancer; 2001 Jan; 37(1):114-21. PubMed ID: 11165138
[TBL] [Abstract][Full Text] [Related]
20. Aberrant expression of cell cycle regulatory genes predicts overall and disease free survival in malignant pleural mesothelioma patients.
Bahnassy AA; Zekri AR; Abou-Bakr AA; El-Deftar MM; El-Bastawisy A; Sakr MA; El-Sherif GM; Gaafar RM
Exp Mol Pathol; 2012 Aug; 93(1):154-61. PubMed ID: 22504106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]